Abbott Laboratories Under DOJ Investigation Into 2022 Baby Formula Plant Shutdown: Report
The Justice Department's consumer-protection branch is conducting an investigation into infant formula maker Abbott Laboratories (NYSE: ABT).
Reckitt Sees US Baby Food Formula Crisis Persisting Till Spring: Report
Enfamil maker Reckitt Benckiser Group Plc (OTC:RBGLY) (OTC:RBGPF) sees the near year-long infant formula shortage in the U.S. that prompted…
New Starbucks CEO To Focus On Unions, Pay And Benefits As Part Of ‘Reinvention’ Plan
Starbucks Corporation (NYSE: SBUX) surprised everyone this week by naming Reckitt Benckiser Group plc (OTC: RBGLY)
Why This Starbucks Analyst Is Surprised By New CEO Choice — And Optimistic
Starbucks Corporation (NYSE: SBUX) announced late Thursday the appointment of Reckitt Benckiser Group plc (OTC: RBGLY) top brass
Dettol Maker Reckitt Benckiser’s CEO Steps Down
England-based consumer company Reckitt Benckiser Group Plc (OTC:RBGLY) (OTC:RBGPF) Chief Executive Officer Laxman Narasimhan will step down at the end of September.…
Morning Brief: Top Financial Stories Dominating on Wednesday, May 25
Reuters
Ford To Pay $19.2M In Multi-State Settlement For False Advertising Claims
More Companies Join Race To Ease US Baby Formula Supply Crunch
Danone SA (OTC: DANOY) has been doubling shipments to the U.S. of Neocate formula for infants allergic to cow's milk, while Enfamil maker Reckitt is also working to boost supplies amid a nationwide shortage, company executives said.
Bernstein Downgrades Reckitt Benckiser Group to Underperform
Bernstein analyst Bruno Monteyne downgrades Reckitt Benckiser Group (OTC:RBGLY) from Market Perform to Underperform.